Hikma Ventures Overview
Founded in August 2015, Hikma Ventures is the corporate venture capital arm of Hikma Pharmaceuticals. It invests in global startups in the digital health and life sciences sectors, aiming to leverage Hikma's expertise and global presence to accelerate revenue growth and enhance value creation. The firm focuses on businesses where its resources can help differentiate Hikma's products and broaden its offerings.
Is Hikma Ventures the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Hikma Ventures, along with a list of other relevant VCs, is available on Hopohopo.io.
Hikma Ventures
Investment focus
Product type
- Software
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- Digital & Consumer health
- Health Data, Healthcare Systems & Infrastructure
- MedTech & Devices
- PharmaTech
Stages
Series A
First ticket size
US$30,000,000 - US$30,000,000
How to approach funds like Hikma Ventures
When approaching Hikma Ventures, founders should highlight how their solution can integrate with or complement established healthcare systems, especially where strategic partnerships with a global pharmaceutical player could accelerate adoption. Emphasize clear pathways to commercialization and scalability, particularly in regulated markets, and be prepared to discuss how your technology or business model can create tangible value for both patients and healthcare providers. Demonstrating a strong understanding of the healthcare value chain and potential synergies with Hikma’s distribution or product portfolio will resonate strongly.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
